Literature DB >> 22072811

The importance of PK/PD data-key biological answers needed to evaluate the success of potential cancer therapeutics.

Rakesh Kumar1, Benjamin Suttle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22072811     DOI： 10.1158/1535-7163.MCT-11-0728

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  2 in total

1.  Development and characterization of a differentiated thyroid cancer cell line resistant to VEGFR-targeted kinase inhibitors.

Authors:  Crescent R Isham; Brian C Netzel; Ayoko R Bossou; Dragana Milosevic; Kendall W Cradic; Stefan K Grebe; Keith C Bible
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

2.  Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells.

Authors:  Nobuhiko Yokoyama; Tomoya Matsunobu; Yoshihiro Matsumoto; Jun-Ichi Fukushi; Makoto Endo; Mihoko Hatano; Akira Nabeshima; Suguru Fukushima; Seiji Okada; Yukihide Iwamoto
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.